The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
This session will provide a general update on the 340B Drug Pricing Program that includes the topics of litigation status, manufacturer restrictions, and any anticipated regulatory challenges related to the program. Given the program's current status, advocacy tools will be provided to help defend the program at the state and federal levels.
Learning Objectives
Understand the relationship between financial stability of health centers and their ability to provide more effective, equitable care.
Discuss how adoption of the Raising the Bar principles and action-steps can enhance existing health center goals and advance equity, inform strategic planning, and enhance population health.
Describe recommendations to support health centers with value-based care and payment models that include reimbursement for addressing social needs, partnering with community, and investing in workforce development in CHCs.
Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.